Optimal therapeutic strategies in the setting of post-infarct no reflow: the need for a pathogenetic classification.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it.

1. Intralesional versus intracoronary administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention in patients with acute coronary syndromes: A meta-analysis of randomized controlled trials.Medicine · 2017
   Pooled it
2. Short-Term Effects of Verapamil and Diltiazem in the Treatment of No Reflow Phenomenon: A Meta-Analysis of Randomized Controlled Trials.BioMed research international · 2015
   Pooled it
3. Admission Serum Total Brain-Derived Neurotrophic Factor and Angiographic No-Reflow in Non-ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention.Medicina (Kaunas, Lithuania) · 2026
   Observational
4. Platelet/lymphocyte ratio for prediction of no-reflow phenomenon in ST-elevation myocardial infarction managed with primary percutaneous coronary intervention.Journal of clinical and translational research · 2020
   Article
5. Predictors of no-reflow in patients undergoing primary percutaneous coronary intervention. Thrombus aspiration was protective.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2018
   Article
6. Temporal Evolution of Myocardial Hemorrhage and Edema in Patients After Acute ST-Segment Elevation Myocardial Infarction: Pathophysiological Insights and Clinical Implications.Journal of the American Heart Association · 2016
   Article
7. Myocardial Hemorrhage After Acute Reperfused ST-Segment-Elevation Myocardial Infarction: Relation to Microvascular Obstruction and Prognostic Significance.Circulation. Cardiovascular imaging · 2016
   Article
8. Intracoronary administration of anisodamine and nicorandil in individuals undergoing primary percutaneous coronary intervention for acute inferior myocardial infarction: A randomized factorial trial.Experimental and therapeutic medicine · 2015
   Article
9. The increased cardiovascular risk in patients affected by autoimmune diseases: review of the various manifestations.Journal of clinical medicine research · 2015
   Review
10. Magnetic resonance imaging characterization of circumferential and longitudinal strain under various coronary interventions in swine.World journal of radiology · 2013
    Article
11. Effects of intravenous diltiazem in a rat model of experimental coronary thrombotic microembolism.Experimental and therapeutic medicine · 2013
    Article
12. Telmisartan protects against microvascular dysfunction during myocardial ischemia/reperfusion injury by activation of peroxisome proliferator-activated receptor γ.BMC cardiovascular disorders · 2013
    Article
13. CMR of microvascular obstruction and hemorrhage in myocardial infarction.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2012
    Review
14. Non-invasive evaluation of myocardial reperfusion by transthoracic Doppler echocardiography and single-photon emission computed tomography in patients with anterior acute myocardial infarction.Cardiovascular ultrasound · 2011
    Article
15. Clinical Predictors of Incomplete ST-Segment Resolution in the Patients With Acute ST Segment Elevation Myocardial Infarction.Korean circulation journal · 2009
    Article
16. Pretreatment with simvastatin reduces myocardial no-reflow by opening mitochondrial K(ATP) channel.British journal of pharmacology · 2006
    Article
17. Microvascular obstruction after successful fibrinolytic therapy in acute myocardial infarction. Comparison of reteplase vs reteplase+abciximab: A cardiovascular magnetic resonance study.Heart international · 2006
    Article
18. Non-invasive imaging of microvascular damage.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
    Review
19. No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction.Indian heart journal
    Review
20. Myocardial preservation during primary percutaneous intervention: It's time to rethink?Indian heart journal
    Article

Corrections and comments

• Comment on
  Nicorandil versus isosorbide dinitrate as adjunctive treatment to direct balloon angioplasty in acute myocardial infarction.2004

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as